These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38958228)

  • 1. Robust growth hormone responses to GH-releasing peptide 2 in adolescents.
    Onuki T; Hiroaki T; Sawano K; Shibata N; Nyuzuki H; Ogawa Y; Okada M; Sone H; Nagasaki K
    J Pediatr Endocrinol Metab; 2024 Aug; 37(8):730-733. PubMed ID: 38958228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of clonidine testing for the diagnosis of growth hormone deficiency in children and adolescents.
    Ibba A; Guzzetti C; Casula L; Salerno M; Di Iorgi N; Allegri AME; Cappa M; Maghnie M; Loche S
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):765-770. PubMed ID: 30171702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment.
    Chaler EA; Rivarola MA; Guerci B; Ciaccio M; Costanzo M; Travaglino P; Maceiras M; Pagani S; Meazza C; Bozzola E; Barberi S; Bozzola M; Belgorosky A
    Horm Res; 2006; 66(5):231-5. PubMed ID: 16912509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of different cut-off limits of peak GH after GHRH-arginine stimulatory test, single IGF1 measurement, or their combination in identifying adult patients with GH deficiency.
    Bogazzi F; Manetti L; Lombardi M; Giovannetti C; Raffaelli V; Urbani C; Scattina I; Pepe P; Iannelli A; Martino E; Rossi G
    Eur J Endocrinol; 2011 May; 164(5):685-93. PubMed ID: 21307143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6.
    Popovic V; Pekic S; Golubicic I; Doknic M; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 2002 May; 87(5):2095-9. PubMed ID: 11994347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of insulin like growth factor (IGF)-1 and IGF-binding protein-3 in diagnosis of Growth Hormone Deficiency in short stature children.
    Haghshenas Z; Sotoudeh K; Karamifar H; Karamizadeh Z; Amirhakimi G
    Indian J Pediatr; 2009 Jul; 76(7):699-703. PubMed ID: 19381505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of growth hormone response to GHRH plus arginine test in children with idiopathic short stature: role of peak time.
    Castagno M; Monzani A; Zanetta S; Genoni G; Giglione E; Ricotti R; Bona G; Prodam F; Bellone S
    J Endocrinol Invest; 2018 Aug; 41(8):977-983. PubMed ID: 29423542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency.
    Chihara K; Shimatsu A; Hizuka N; Tanaka T; Seino Y; Katofor Y;
    Eur J Endocrinol; 2007 Jul; 157(1):19-27. PubMed ID: 17609397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies.
    Maghnie M; Ambrosini L; Cappa M; Pozzobon G; Ghizzoni L; Ubertini MG; di Iorgi N; Tinelli C; Pilia S; Chiumello G; Lorini R; Loche S
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2900-5. PubMed ID: 16684828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance Between Stimulated and Spontaneous Growth Hormone Levels in Short Children Is Dependent on Cut-Off Level and Partly Explained by Refractoriness.
    Lennartsson O; Nilsson O; Lodefalk M
    Front Endocrinol (Lausanne); 2020; 11():584906. PubMed ID: 33281744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
    Corneli G; Di Somma C; Baldelli R; Rovere S; Gasco V; Croce CG; Grottoli S; Maccario M; Colao A; Lombardi G; Ghigo E; Camanni F; Aimaretti G
    Eur J Endocrinol; 2005 Aug; 153(2):257-64. PubMed ID: 16061832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment and health-related quality of life in children and adolescents: A national, prospective, one-year controlled study.
    Butler G; Turlejski T; Wales G; Bailey L; Wright N
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):304-313. PubMed ID: 31077606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.